Stay updated on CTX110 in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX110 in B-Cell Malignancies Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The Locations section was updated with additional sites across the United States, Australia, and Canada, and some previous location blocks were removed; a new revision tag v3.3.3 is now shown.
    Difference
    2%
    Check dated 2025-12-23T09:24:33.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:46:15.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; no visible edits to core study content, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T12:51:46.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    - Removed the government funding status notice from the page; study content and data remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:26:37.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The Study Record Dates section now shows 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)' instead of the previous labels. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:06:44.000Z thumbnail image
  9. Check
    69 days ago
    Change Detected
    Summary
    Results posted on 2025-10-24 for the CTX110 CARBON study include DLT data, objective response rates, survival metrics, SAEs, PK data, and laboratory results through up to 5 years. The plan also removes several long-term endpoints (DOR, DOCB, TFFS, PFS, OS) from the results section.
    Difference
    3%
    Check dated 2025-10-26T20:38:08.000Z thumbnail image

Stay in the know with updates to CTX110 in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.